Lopinavir/Ritonavir Mylan Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

lopinavir/ritonavir mylan

mylan pharmaceuticals limited - lopinavir, ritonavir - hiv infektioner - antivirale midler til systemisk anvendelse - lopinavir/ritonavir angives i kombination med andre antiretrovirale lægemidler til behandling af human immundefekt virus (hiv-1) inficeret voksne, unge og børn over 2 år. valget af lopinavir/ritonavir til at behandle proteasehæmmer oplevet hiv-1-inficerede patienter bør være baseret på individuelle viral resistens test og historie behandling af patienter.

Xtandi Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Abboticin 200 mg granulat til oral suspension, enkeltdosisbeholder Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

abboticin 200 mg granulat til oral suspension, enkeltdosisbeholder

amdipharm limited - erythromycinethylsuccinat - granulat til oral suspension, enkeltdosisbeholder - 200 mg